Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute respiratory failure due to Aspergillus niger infection with acute fibrinous and organazing pneumonia: A case report.
Okamura K, Noro R, Fujita K, Kure S, Kunugi S, Takano H, Miyashita R, Tozuka T, Tanaka T, Sugano T, Sakurai Y, Suzuki A, Suga M, Hayashi A, Saito Y, Kubota K, Seike M, Gemma A. Okamura K, et al. Among authors: kubota k. Respir Med Case Rep. 2022 Mar 23;37:101641. doi: 10.1016/j.rmcr.2022.101641. eCollection 2022. Respir Med Case Rep. 2022. PMID: 35368801 Free PMC article.
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
Kitamura K, Kubota K, Ando M, Takahashi S, Nishijima N, Sugano T, Toyokawa M, Miwa K, Kosaihira S, Noro R, Minegishi Y, Seike M, Yoshimura A, Gemma A. Kitamura K, et al. Among authors: kubota k. Cancer Chemother Pharmacol. 2013 Feb;71(2):457-61. doi: 10.1007/s00280-012-2026-4. Epub 2012 Nov 21. Cancer Chemother Pharmacol. 2013. PMID: 23178954
Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancer.
Noro R, Yoshimura A, Yamamoto K, Miyanaga A, Mizutani H, Minegishi Y, Seike M, Kubota K, Kosaihira S, Hino M, Ando M, Nomura K, Okano T, Kobayashi K, Uematsu K, Gemma A; East Japan Chesters Group. Noro R, et al. Among authors: kubota k. Anticancer Res. 2013 Mar;33(3):1117-23. Anticancer Res. 2013. PMID: 23482789 Clinical Trial.
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.
Noro R, Seike M, Zou F, Soeno C, Matsuda K, Sugano T, Nishijima N, Matsumoto M, Kitamura K, Kosaihira S, Minegishi Y, Yoshimura A, Kubota K, Gemma A. Noro R, et al. Among authors: kubota k. BMC Cancer. 2015 Feb 6;15:31. doi: 10.1186/s12885-015-1019-1. BMC Cancer. 2015. PMID: 25886066 Free PMC article.
3,619 results